| Financial Year |
March 31 2023 |
| Monetary Funds |
350,347,083.86 |
| Held-for-trading Financial Assets |
78,093,545.96 |
| Notes Receivable |
-- |
| Accounts Receivable |
320,182,415.59 |
| Advances to Suppliers |
118,738,138.64 |
| Other Receivables |
39,717,515.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
868,732,182.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,368,983.13 |
| Total Current Assets |
1,863,179,864.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
19,573,191.83 |
| Investment Properties |
-- |
| Fixed Assetes |
616,598,554.24 |
| Under-construction Projects |
417,523,830.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
255,707,065.81 |
| R&D expenses |
-- |
| Goodwill |
295,050,344.21 |
| Long-Term Deferred and Prepaid Expenses |
14,157,226.42 |
| Deferred Income Tax Assets |
91,449,078.40 |
| Other Non-Current Assets |
4,000,000.00 |
| Sub-Total of Non-Current Assets |
1,827,497,300.55 |
| Total Assets |
3,690,677,165.37 |
| Short-Term Loans |
478,992,847.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
24,349,180.58 |
| Accounts Payable |
321,110,139.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
53,221,396.11 |
| Taxes Payable |
59,508,764.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
120,022,645.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
204,157,720.57 |
| Other Current Liabilities |
16,305,037.73 |
| Sub-Total of Current Liabilities |
1,320,125,173.75 |
| Long-term Loans |
551,453,427.15 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,007,463.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
571,925,841.91 |
| Total Liabilities |
1,892,051,015.66 |
| Paid-In Capital(Or Share Stock) |
389,383,616.00 |
| Capital Surplus |
500,808,328.86 |
| Surplus Reserve |
23,845,027.04 |
| LESS:Treasury Stock |
11,175,605.88 |
| Undistributed Profits |
925,007,988.59 |
| Minority Stockholder's Interest |
-3,406,321.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,802,032,471.42 |
| Owner's Equity（Stockholder's Equity） |
1,798,626,149.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,690,677,165.37 |
